QA: Mersana Therapeutics Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001442836_2018_Mersana_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001442836, Mersana Therapeutics Inc

  xvar xval
0 AssetsCurrent 117,543,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,319,000
3 remainder_Assets 10,853,000
4 LiabilitiesCurrent 31,881,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,462,000
9 ResearchAndDevelopmentExpense 46,700,000
10 remainder_Expenses 0
11 remainder_Revenues 17,545,000
12 remainder_NetIncome 910,000
13 remainder_ComprehensiveNetIncome -149,000
  yvar yval
0 Assets 130,715,000
1 Liabilities 31,881,000
2 Expenses 57,162,000
3 Revenues 17,545,000
4 StockholdersEquity 98,834,000
5 NetIncome -38,707,000
6 ComprehensiveNetIncome -38,781,500
7 BaseVar 119,181,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.17
9 EconomicCapitalRatio 3.14

Edgar->Model Mapping

Feature Distribution